January 08, 2008; 70 (2) Articles
Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy
C. L. Skura, E. G. Fowler, G. T. Wetzel, M. Graves, M. J. Spencer
First published October 17, 2007, DOI: https://doi.org/10.1212/01.WNL.0000287070.00149.a9
C. L. Skura
E. G. Fowler
G. T. Wetzel
M. Graves
Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy
C. L. Skura, E. G. Fowler, G. T. Wetzel, M. Graves, M. J. Spencer
Neurology Jan 2008, 70 (2) 137-143; DOI: 10.1212/01.WNL.0000287070.00149.a9
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 70 no. 2 137-143
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published October 17, 2007.
Article Versions
- Previous version (October 17, 2007 - 12:50).
- You are viewing the most recent version of this article.
Copyright & Usage:
© 2008
Author Disclosures
- C. L. Skura, DPT,
- E. G. Fowler, PhD, PT,
- G. T. Wetzel, MD, PhD,
- M. Graves, MD and
- M. J. Spencer, PhD
- C. L. Skura, DPT,
- E. G. Fowler, PhD, PT,
- G. T. Wetzel, MD, PhD,
- M. Graves, MD and
- M. J. Spencer, PhD
- From the UCLA Department of Orthopaedic Surgery, Tarjan Center for Disabilities at UCLA (E.G.F.), UCLA Department of Pediatrics (G.T.W., M.J.S.), and UCLA Department of Neurology (M.G., M.J.S.), University of California (C.L.S.), Los Angeles.
- Address correspondence and reprint requests to Dr. Melissa J. Spencer, Department of Neurology, David Geffen School of Medicine at UCLA, 635 Charles Young Drive South, NRB1 Room 401, Los Angeles, CA 90095-7334 mspencer{at}mednet.ucla.edu
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Brief Communications
Pilot trial of albuterol in Duchenne and Becker muscular dystrophyE. G. Fowler, M. C. Graves, G. T. Wetzel et al.Neurology, March 22, 2004 -
Article
A Prospective, Quantitative Study of the Natural History of Facioscapulohumeral Muscular Dystrophy (FSHD)Implications for Therapeutic Trials et al.Neurology, January 01, 1997 -
Articles
Pilot trial of albuterol in facioscapulohumeral muscular dystrophyJ. T. Kissel, M. P. McDermott, R. Natarajan et al.Neurology, May 01, 1998 -
Patient Page
New treatment alternatives for Duchenne and Becker muscular dystrophySantiago Restrepo et al.Neurology, March 22, 2004